A Randomised, open labelled study in anti-TNFa inadequate responders to investigate the mechanisms for Response - Resistance to Rituximab versus Tocilizumab in RA (R4-RA)
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Rituximab (Primary) ; Tocilizumab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms R4-RA
- 17 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 17 Jan 2017 Status changed from completed to recruiting.
- 02 Dec 2016 Status changed from recruiting to completed.